Last reviewed · How we verify
NCT04015635
The Role of the Immune and Inflammatory Systems in Hypertension
trial testing None involved in Hypertension in 160 participants. Status unknown.
1 September 2021
Quick facts
| Lead sponsor | University of Glasgow |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 160 |
| Start date | 7 May 2019 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 September 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- None involved
Conditions studied
- Hypertension — all drugs for Hypertension →
- Inflammation — all drugs for Inflammation →
- Vascular Diseases — all drugs for Vascular Diseases →
Sponsor
University of Glasgow
Who can join
Adults 18 to 55, any sex, with Hypertension or Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To define the cytokine and cellular immune signature of primary hypertension. Cross sectional clinical/laboratory study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Vascular phenotypes in early hypertension.
Murray EC, Delles C, Orzechowski P, Renc P, et al · · 2023 · cited 7× · PMID 36528682 · DOI 10.1038/s41371-022-00794-7
Verify or expand the search:
- PubMed search for NCT04015635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other University of Glasgow trials
Trials by the same sponsor.
- NCT07500792 — Effect of Early Time-Restricted Eating on Appetite, Appetite-Regulatory Hormones and Energy Intake · NA · not yet recruiting
- NCT07388121 — The Effect of Vitamin C Supplementation on Gut Microbiota Composition and Function in Healthy Adults · NA · recruiting
- NCT07130513 — Investigating the Feasibility of Krill Oil Intervention to Improve Muscle Function in Adults With Long-term Conditions · NA · recruiting
- NCT06895837 — Effect of Exercise on Appetite in Response to Meals During Energy Restriction · NA · recruiting
- NCT06939244 — Investigating the Effects of Krill Oil on the Recovery From Muscle Damaging Exercise: a Randomised Controlled Trial · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04015635 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Glasgow
- Last refreshed: 14 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04015635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing